HSF1 and non-small cell lung carcinoma: Previous studies showed that low celastrol and erastin concentrations activated HSF1 to protect cells from proteotoxic stress, and HSF1 knockdown further enhanced non-small cell lung cancer cell death in vitro and vivo.